Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 6 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 21 most recent Form 4 transactions.
| Jun 3 | XENE | Xenon Pharmaceuticals Inc. | AGRANT◆ | 1,593 | — | — | — | Open the original filing on SEC.gov |
| Jun 3 | XENE | Xenon Pharmaceuticals Inc. | AGRANT◆ | 10,507 | — | — | — | Open the original filing on SEC.gov |
| Jun 1 | XENE | Xenon Pharmaceuticals Inc. | MEXER◆ | 2,645 | — | — | — | Open the original filing on SEC.gov |
| Jun 1 | XENE | Xenon Pharmaceuticals Inc. | FTAX | 1,416 | $53.41 | $75.6K | -5.1% | Open the original filing on SEC.gov |
| Jun 1 | XENE | Xenon Pharmaceuticals Inc. | MEXER | 2,645 | — | — | +10.6% | Open the original filing on SEC.gov |
| Dec 9, 2025 | ADVM | Adverum Biotechnologies,… | DTOISS◆ | 10,450 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | ADVM | Adverum Biotechnologies,… | DTOISS◆ | 10,520 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | ADVM | Adverum Biotechnologies,… | DTOISS◆ | 4,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | ADVM | Adverum Biotechnologies,… | DTOISS◆ | 4,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | ADVM | Adverum Biotechnologies,… | DTOISS◆ | 4,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | ADVM | Adverum Biotechnologies,… | DTOISS◆ | 4,500 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | ADVM | Adverum Biotechnologies,… | UTENDR | 5,000 | — | — | -100.0% | Open the original filing on SEC.gov |
| Jun 17, 2025 | ADVM | Adverum Biotechnologies,… | AGRANT◆ | 10,450 | — | — | — | Open the original filing on SEC.gov |
| Jun 5, 2025 | XENE | Xenon Pharmaceuticals Inc. | AGRANT◆ | 2,645 | — | — | — | Open the original filing on SEC.gov |
| Jun 5, 2025 | XENE | Xenon Pharmaceuticals Inc. | AGRANT◆ | 17,012 | — | — | — | Open the original filing on SEC.gov |
| May 21, 2025 | SLRN | ACELYRIN, Inc. | DTOISS◆ | 155,450 | — | — | — | Open the original filing on SEC.gov |
| May 21, 2025 | SLRN | ACELYRIN, Inc. | DTOISS◆ | 23,243 | — | — | — | Open the original filing on SEC.gov |
| May 21, 2025 | SLRN | ACELYRIN, Inc. | DTOISS◆ | 92,158 | — | — | — | Open the original filing on SEC.gov |
| May 21, 2025 | SLRN | ACELYRIN, Inc. | DTOISS | 15,000 | — | — | -100.0% | Open the original filing on SEC.gov |